International Patent: CRISPR SAM BIOSENSOR CELLS AND CELL LINES AND METHODS OF USE THEREOF

GENEVA, June 19 -- REGENERON PHARMACEUTICALS, INC. filed a patent application (US2025/049897) for “CRISPR SAM BIOSENSOR CELLS AND CELL LINES AND METHODS OF USE THEREOF”. With publication no. WO/2026/080515, here are the other details related to the patent application:

Kind: Later publication of international search report [A3]

IPC: C12N 9/22

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....